24/7 Market News Snapshot 13 May, 2025 – Intelligent Bio Solutions Inc. Common Stock (NASDAQ:INBS)
DENVER, Colo., 13 May, 2025 (www.247marketnews.com) – (Nasdaq:INBS) are discussed in this article.
Intelligent Bio Solutions Inc. (Nasdaq:INBS) has demonstrated significant momentum in the financial markets and its operational performance, with its stock recently showing an upward trend, opening at $1.28 and trading at $1.35, reflecting an approximate gain of 10.66%. This surge surpasses the previous session’s close of $1.22, highlighting a strong bullish sentiment among investors, as evidenced by a trading volume of 504.92K shares, which indicates heightened market interest.
Simultaneously, the company has reported impressive financial results for its third quarter ending March 31, 2025. INBS achieved a sequential revenue growth of 20% compared to the previous quarter, driven largely by an increase in recurring higher-margin cartridge sales, which now represent 58% of total revenue year-to-date. The addition of 35 new accounts this quarter brings the company’s total active accounts to over 450, showcasing effective customer acquisition and expansion strategies.
President and CEO Harry Simeonidis emphasized the critical role of cartridge adoption in enhancing business fundamentals. The company also achieved a significant 91% increase in gross profits year-over-year, amounting to $341,368, alongside reduced operational losses due to improved efficiency and cost control measures.
Intelligent Bio Solutions continues to enhance its global presence through localized initiatives, including upgrades to its drug screening systems and targeted marketing efforts across Europe and the Asia-Pacific region. This strategic positioning not only broadens access to its innovative fingerprinting drug testing solutions, which are essential for safety-critical industries, but also sets the stage for sustained growth in an evolving marketplace. As the company moves forward, market participants are advised to monitor key resistance and support levels, particularly around $1.40 and $1.25, respectively, to gauge future trading opportunities.
Related news for (INBS)
- Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
- 24/7 Market News Snapshot 16 July, 2025 – Intelligent Bio Solutions Inc. Common Stock (NASDAQ:INBS)
- 24/7 Market News Snapshot 15 July, 2025 – Intelligent Bio Solutions Inc. Common Stock (NASDAQ:INBS)
- Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
- Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion